Literature DB >> 31722255

In situ miRNA delivery from a hydrogel promotes osteogenesis of encapsulated mesenchymal stromal cells.

J Carthew1, I Donderwinkel1, S Shrestha1, V X Truong1, J S Forsythe1, J E Frith2.   

Abstract

Hydrogels are attractive candidates for use in tissue-engineering and the encapsulation and subsequent differentiation of mesenchymal stem/stromal cells (MSCs) is a strategy that holds great promise for the repair and regeneration of bone and cartilage. However, MSCs are well-known for their sensitivity to mechanical cues, particularly substrate stiffness, and so the inherent softness of hydrogels is poorly matched to the mechanical cues that drive efficient osteogenesis. One approach to overcome this limitation is to harness mechanotransductive signalling pathways and override the signals cells receive from their environment. Previous reports demonstrate that mechanosensitive miRNAs, miR-100-5p and miR-143-3p can enhance MSC osteogenesis, using a complex multi-step procedure to transfect, encapsulate and differentiate the cells. In this study, we develop and characterise a facile system for in situ transfection of MSCs encapsulated within a light-crosslinkable gelatin-PEG hydrogel. Comparing the influence of different transfection agents and hydrogel compositions, we show that particle size, charge, and hydrogel mechanical properties all influence the diffusion of embedded transfection agent complexes. By incorporating both MSCs and transfection agents into the hydrogels we demonstrate successful in situ transfection of encapsulated MSCs. Comparing the efficacy of pre- and in situ transfection of miR-100-5p/miR-143-3p on the osteogenic capacity of hydrogel-encapsulated MSCs, our data demonstrates superior mineralisation and osteogenic gene expression following in situ transfections. Overall, we demonstrate a simple, one-pot system for in situ transfection of miRNAs to enhance MSC osteogenic potential and thus demonstrates significant promise to improve the efficiency of MSC differentiation in hydrogels for bone tissue-engineering applications. STATEMENT OF SIGNIFICANCE: Mesenchymal stromal cells (MSCs) are sensitive to cues from their surrounding microenvironment. Osteogenesis is enhanced in MSCs grown on stiffer substrates, but this is limited when using hydrogels for bone tissue-engineering. Modulating pro-osteogenic genes with mechanosensitive microRNAs (miRNAs) represents a potential tool to overcome this challenge. Here we report a hydrogel platform to deliver miRNAs to encapsulated MSCs. We characterise effects of hydrogel composition and transfection agent type on their mobility and transfection efficiency, demonstrating successful in situ transfection of MSCs and showing that miRNAs can significantly enhance osteogenic mineral deposition and marker gene expression. This system was simpler and more effective than conventional 2D transfection prior to encapsulation and therefore holds promise to improve MSC differentiation in bone tissue-engineering.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Hydrogels; Mesenchymal stromal cells; Osteogenesis; Transfection; microRNAs

Mesh:

Substances:

Year:  2019        PMID: 31722255     DOI: 10.1016/j.actbio.2019.11.016

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  16 in total

1.  Superior CKIP-1 sensitivity of orofacial bone-derived mesenchymal stem cells in proliferation and osteogenic differentiation compared to long bone-derived mesenchymal stem cells.

Authors:  Xin Huang; Bingkun Cheng; Wen Song; Le Wang; Yanyuan Zhang; Yan Hou; Yu Song; Liang Kong
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

Review 2.  Advancements in Hydrogel-Based Drug Sustained Release Systems for Bone Tissue Engineering.

Authors:  Yunfan Zhang; Tingting Yu; Liying Peng; Qiannan Sun; Yan Wei; Bing Han
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

Review 3.  Hydrogels as Drug Delivery Systems: A Review of Current Characterization and Evaluation Techniques.

Authors:  Margaux Vigata; Christoph Meinert; Dietmar W Hutmacher; Nathalie Bock
Journal:  Pharmaceutics       Date:  2020-12-07       Impact factor: 6.321

4.  Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100.

Authors:  Lei Cao; Tian Tian; Yuanbo Huang; Shiqin Tao; Xiaohong Zhu; Mifang Yang; Jing Gu; Guangdong Feng; Yinni Ma; Rushan Xia; Wenrong Xu; Lei Wang
Journal:  J Nanobiotechnology       Date:  2021-01-11       Impact factor: 10.435

5.  MiR-143-3p Inhibits Osteogenic Differentiation of Human Periodontal Ligament Cells by Targeting KLF5 and Inactivating the Wnt/β-Catenin Pathway.

Authors:  Kaixin Wangzhou; Zhiying Lai; Zishao Lu; Wanren Fu; Cheng Liu; Zhengeng Liang; Yi Tan; Conghui Li; Chunbo Hao
Journal:  Front Physiol       Date:  2021-02-02       Impact factor: 4.566

Review 6.  Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing.

Authors:  L Andrée; F Yang; R Brock; S C G Leeuwenburgh
Journal:  Mater Today Bio       Date:  2021-03-06

7.  Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway.

Authors:  Wu Yang; Weiwen Zhu; Yunfei Yang; Minkang Guo; Husun Qian; Weiqian Jiang; Yu Chen; Chengjie Lian; Zijie Xu; Haobo Bai; Tingmei Chen; Jian Zhang
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832

Review 8.  Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects.

Authors:  Noha Attia; Mohamed Mashal; Gustavo Puras; Jose Luis Pedraz
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

Review 9.  Physical and mechanical cues affecting biomaterial-mediated plasmid DNA delivery: insights into non-viral delivery systems.

Authors:  Valeria Graceffa
Journal:  J Genet Eng Biotechnol       Date:  2021-06-17

Review 10.  Small and Long Non-coding RNAs as Functional Regulators of Bone Homeostasis, Acting Alone or Cooperatively.

Authors:  Mateusz Sikora; Krzysztof Marycz; Agnieszka Smieszek
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.